Head and Neck Cancers Clinical Trials

10 recruiting

Head and Neck Cancers Trials at a Glance

16 actively recruiting trials for head and neck cancers are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Villejuif, Stanford, and Columbus. Lead sponsors running head and neck cancers studies include Chang Gung Memorial Hospital, Gustave Roussy, Cancer Campus, Grand Paris, and Centre for Research and Technology Hellas.

Browse head and neck cancers trials by phase

Treatments under study

About Head and Neck Cancers Clinical Trials

Looking for clinical trials for Head and Neck Cancers? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Head and Neck Cancers trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Head and Neck Cancers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris5,909 enrolled1 locationNCT06907095
Recruiting
Not Applicable

Feasibility Study of CBCT for IGRT in Cancer Patients

Breast CancerLiver CancerHead and Neck Cancers+3 more
Varian, a Siemens Healthineers Company50 enrolled4 locationsNCT06681233
Recruiting
Phase 1

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Head and Neck CarcinomaHead and Neck CancerHead and Neck Squamous Cell Carcinoma+2 more
University of Chicago30 enrolled1 locationNCT05526924
Recruiting

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Recurrent Head and Neck Squamous Cell CarcinomaHead and Neck Cancers- Squamous CellHead and Neck Cancer Metastatic
National Taiwan University Hospital30 enrolled1 locationNCT06678724
Recruiting
Phase 1

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Head and Neck CancerSolid TumorsHNSCC+3 more
VLP Therapeutics41 enrolled1 locationNCT06736379
Recruiting

Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap

Head and Neck Cancers
University Hospital, Toulouse200 enrolled9 locationsNCT06771336
Recruiting
Not Applicable

Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care

Head and Neck CancersLaryngeal Carcinoma
University Medical Center Groningen140 enrolled1 locationNCT06940505
Recruiting
Not Applicable

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

Breast CancerColon CancerHead and Neck Cancers
Centre for Research and Technology Hellas180 enrolled1 locationNCT07108517
Recruiting

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Lung CancerHead and Neck CancerLip Cancer+2 more
Stanford University200 enrolled1 locationNCT00568490
Recruiting
Not Applicable

Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy

Head and Neck Cancers
University of Zurich25 enrolled1 locationNCT06870799
Recruiting
Not Applicable

Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection

Prostate Cancer SurgeryHead and Neck Cancers
University Hospitals Coventry and Warwickshire NHS Trust87 enrolled1 locationNCT06676943
Recruiting
Not Applicable

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

AgingHead and Neck Cancers - TonsilsHigh-intensity Interval Training
Chang Gung Memorial Hospital180 enrolled1 locationNCT06851988
Recruiting
Not Applicable

StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients

Acute Radiation DermatitisHead and Neck Cancers
National University Hospital, Singapore100 enrolled1 locationNCT03394417
Recruiting
Not Applicable

Comprehensive Outcomes for After Cancer Health

Breast CancerMetastatic Breast CancerGastric Cancer+8 more
Pack Health625 enrolled7 locationsNCT05349227
Recruiting
Phase 1

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Cervical CancerAnal CancerPenile Cancer+5 more
The Affiliated Hospital of Qingdao University18 enrolled1 locationNCT06544720
Recruiting
Not Applicable

Submental Flap for the Reconstruction of Hypopharyngectomy

Head and Neck Cancers - Hypopharyngeal
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University40 enrolled1 locationNCT06161779